Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors

by Seini Moimoi | Dec 19, 2019 | Portfolio News

Axonics® Granted Six U.S. Patents and Allowed Three Additional Patents Related to its Implantable Sacral Neuromodulation Technology

by Seini Moimoi | Dec 19, 2019 | Portfolio News

Aptinyx to Present Preclinical Data Exhibiting Effects of NYX-783 in Models of PTSD and Alcohol Use Disorder at the American College of Neuropsychopharmacology’s Annual Meeting

by Seini Moimoi | Dec 9, 2019 | Portfolio News

Axonics® Provides Survey Results from Physician Seminar Series Showcasing the Recently FDA Approved Axonics r-SNM® System

by Seini Moimoi | Dec 9, 2019 | Portfolio News

Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting

by Seini Moimoi | Dec 7, 2019 | Portfolio News

« Older Entries

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2025 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer